MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), a clinical-stage immuno-oncology drug development company, announces that President and Chief Executive Officer David Hansen is scheduled to...

Royal Philips (NYSE: PHG; AEX: PHIA) today announced it is further enabling connected health by signing an agreement with Validic, a U.S.-based fast-growing company that pioneers a technology...

NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief Executive Officer, plans to participate...

ISE Amsterdam February 9-12 2016 Stand: 1-M60 MARGATE, KENT, 3rd February 2016 - tvONE (www.tvone.com), a leading designer and manufacturer of cutting-edge video and multimedia processing...

Synthetic Biologics, Inc. (NYSE MKT: SYN), a clinical stage company focused on developing therapeutics to protect the gut microbiome, announced today that Jeffrey Riley, CEO, is scheduled to...